ReviewOncology letters2026

Advances in cerebrospinal fluid biomarkers for the diagnosis, treatment and monitoring of leptomeningeal metastases (Review).

Huaixu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.